Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001161697-23-000103
Filing Date
2023-02-13
Accepted
2023-02-13 17:14:58
Documents
44
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q QUARTERLY REPORT FOR 12-31-2022 form_10-q.htm   iXBRL 10-Q 388825
2 RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION OF CEO ex_31-1.htm EX-31 10220
3 RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION OF CFO ex_31-2.htm EX-31 10211
4 SECTION 1350 CERTIFICATION OF CEO ex_32-1.htm EX-32 4985
5 SECTION 1350 CERTIFICATION OF CFO ex_32-2.htm EX-32 4976
  Complete submission text file 0001161697-23-000103.txt   2463414

Data Files

Seq Description Document Type Size
6 INLINE XBRL SCHEMA FILE gstc-20221231.xsd EX-101.SCH 25978
7 INLINE XBRL CALCULATION FILE gstc-20221231_cal.xml EX-101.CAL 28089
8 INLINE XBRL DEFINITION FILE gstc-20221231_def.xml EX-101.DEF 106071
9 INLINE XBRL LABEL FILE gstc-20221231_lab.xml EX-101.LAB 208320
10 INLINE XBRL PRESENTATION FILE gstc-20221231_pre.xml EX-101.PRE 161631
38 EXTRACTED XBRL INSTANCE DOCUMENT form_10-q_htm.xml XML 221414
Mailing Address 719 JADWIN AVENUE RICHLAND WA 99352
Business Address 719 JADWIN AVENUE RICHLAND WA 99352 509-531-1671
GlobeStar Therapeutics Corp (Filer) CIK: 0001502152 (see all company filings)

EIN.: 273480481 | State of Incorp.: WY | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-55072 | Film No.: 23619920
SIC: 2834 Pharmaceutical Preparations